Table 1.
Case | Age | Stage | Histology | Hormone receptor | HER2 status | LC | Prior HCV therapy |
---|---|---|---|---|---|---|---|
1 | 63 | IIA | IDC | negative | negative | negative | positive |
2 | 50 | IIA | IDC | positive | negative | negative | negative |
3 | 50 | IIIA | IDC | positive | negative | negative | negative |
4 | 61 | IIB | IDC | negative | positive | negative | negative |
5 | 71 | IIA | IDC | negative | positive | negative | positive |
6 | 64 | IIA | IDC | positive | positive | positive | negative |
7 | 67 | IV | IDC | negative | negative | positive | positive |
8 | 69 | IIA | IDC | negative | positive | negative | negative |
9 | 60 | IIA | IDC | negative | negative | negative | negative |
10 | 74 | IV | IDC | positive | negative | positive | negative |
LC: liver cirrhosis, HCV: hepatitis C virus, IDC: invasive ductal carcinoma.